文献速递心脏核医学

新型[18F]F标记PET示踪剂XTR004与[13N]氨在冠状动脉疾病心肌灌注成像中的对比评价

Comparative evaluation of a novel [18F] F-Labeled PET tracer XTR004 against [13N] ammonia in myocardial perfusion imaging for coronary artery disease.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-12-17

该前瞻性研究纳入47例疑似或已知冠状动脉疾病患者,在2周内完成一日静息/ATP负荷XTR004与[13N]氨门控PET心肌灌注成像,其中26例接受有创冠状动脉造影。XTR004的图像质量、诊断确定性及心肌灌注特征与[13N]氨相似,所有患者耐受良好且未报告不良事件。

要点

  • XTR004在83%的病例中达到良好至优秀图像质量,[13N]氨为95.7%(P=0.091)。
  • XTR004与[13N]氨的诊断确定性分别为87.2%和89.2%。
  • XTR004与[13N]氨的灵敏度和特异度相似(79%对79%,86%对71%,P=1.00)。

核心结论

  • XTR004 PET心肌灌注成像显示出与[13N]氨PET心肌灌注成像相当的有前景的图像质量、诊断确定性和心肌灌注特征。
  • 未来研究应集中于心肌血流的定量分析,以探索XTR004 PET心肌灌注成像的临床意义。

研究设计与样本

  • 前瞻性纳入47例疑似或已知冠状动脉疾病患者,在2周内完成一日静息/ATP负荷XTR004与[13N]氨心电图门控PET成像。
  • 其中26例患者接受有创冠状动脉造影,19例被确定为血流受限性冠状动脉疾病(狭窄≥70%)。
  • 图像质量(优秀/良好/一般)和判读确定性由两名独立、盲法阅片者评估。

主要发现

  • 尽管XTR004肝脏摄取较高,XTR004在83%的病例中达到良好至优秀图像质量,[13N]氨为95.7%(P=0.091)。
  • XTR004与[13N]氨的诊断确定性(判读为明确异常或正常的病例百分比)分别为87.2%和89.2%。
  • XTR004与[13N]氨心肌灌注成像的灵敏度和特异度相似(79%对79%,86%对71%,P=1.00)。
  • 17节段静息/负荷心肌灌注线性回归显示斜率接近1且R²值优秀(静息:斜率=0.954-1.074,R²=0.990-0.997;负荷:斜率=0.951-1.082,R²=0.971-0.996)。
  • 所有患者对XTR004耐受良好,未报告不良事件。

局限性

  • 未来研究应集中于心肌血流的定量分析,以探索XTR004 PET心肌灌注成像的临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: This study aimed to evaluate image quality, myocardial perfusion, and diagnostic performance of a novel [18F]F-labeled PET tracer, XTR004 PET, myocardial perfusion imaging (MPI) compared with [13N]Ammonia (NH3) PET MPI. METHODS AND RESULTS: Forty-seven patients with suspected or known coronary artery disease (CAD) were prospectively enrolled to undergo one-day rest/ATP-stress XTR004 and NH3 electrocardiograph-gated PET imaging within 2 weeks. Among them, twenty-six patients underwent invasive coronary angiography (ICA), and nineteen were identified with flow-limited CAD (stenosis ≥ 70%). Image quality (excellent/good/average) and certainty of interpretation were evaluated by two independent, blinded readers. Despite a higher liver uptake, XTR004 achieved good to excellent image quality in 83% of cases, comparable to 95.7% of NH3(P = 0.091). Additionally, the diagnostic certainty, measured as the percentage of cases with definitely abnormal or normal interpretations, was similar between XTR004 and NH3, with results of 87.2% and 89.2%, respectively. The sensitivity and specificity levels of XTR004 and NH3 MPI were similar (79% vs. 79%, 86% vs. 71%, P = 1.00). Linear regression of rest/stress myocardial perfusion in 17 segments revealed the linear slope close to unity with excellent R2 value (rest: slope = 0.954-1.074, R2 = 0.990-0.997; stress: slope = 0.951-1.082, R2 = 0.971-0.996). XTR004 was tolerated well by all patients. No adverse events were reported. CONCLUSION: XTR004 PET MPI demonstrated promising image quality, diagnostic certainty and myocardial perfusion characteristics comparable to NH3 PET MPI. Future research should concentrate on the quantitative analysis of myocardial blood flow to explore the clinical implications of XTR004 PET MPI.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Wang P, Ren C, Wang L, et al. Comparative evaluation of a novel [18F] F-Labeled PET tracer XTR004 against [13N] ammonia in myocardial perfusion imaging for coronary artery disease. Eur J Nucl Med Mol Imaging. 2024. PMID: 39681776. doi:10.1007/s00259-024-07004-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。